393 related articles for article (PubMed ID: 29175781)
1. In-silico identification and evaluation of plant flavonoids as dengue NS2B/NS3 protease inhibitors using molecular docking and simulation approach.
Qamar MT; Ashfaq UA; Tusleem K; Mumtaz A; Tariq Q; Goheer A; Ahmed B
Pak J Pharm Sci; 2017 Nov; 30(6):2119-2137. PubMed ID: 29175781
[TBL] [Abstract][Full Text] [Related]
2. Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus ns2b/ns3 protease.
Velmurugan D; Mythily U; Rao K
Protein Pept Lett; 2014; 21(8):815-27. PubMed ID: 23855663
[TBL] [Abstract][Full Text] [Related]
3. Structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) studies showed plant flavonoids as potential inhibitors of dengue NS2B-NS3 protease.
Sarwar MW; Riaz A; Dilshad SMR; Al-Qahtani A; Nawaz-Ul-Rehman MS; Mubin M
BMC Struct Biol; 2018 Apr; 18(1):6. PubMed ID: 29673347
[TBL] [Abstract][Full Text] [Related]
4. Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies.
de Sousa LR; Wu H; Nebo L; Fernandes JB; da Silva MF; Kiefer W; Kanitz M; Bodem J; Diederich WE; Schirmeister T; Vieira PC
Bioorg Med Chem; 2015 Feb; 23(3):466-70. PubMed ID: 25564380
[TBL] [Abstract][Full Text] [Related]
5. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
Dwivedi VD; Tripathi IP; Mishra SK
J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
[TBL] [Abstract][Full Text] [Related]
6. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X
Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156
[TBL] [Abstract][Full Text] [Related]
7. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
[TBL] [Abstract][Full Text] [Related]
8. Pharmacophoric characteristics of dengue virus NS2B/NS3pro inhibitors: a systematic review of the most promising compounds.
Leonel CA; Lima WG; Dos Santos M; Ferraz AC; Taranto AG; de Magalhães JC; Dos Santos LL; Ferreira JMS
Arch Virol; 2018 Mar; 163(3):575-586. PubMed ID: 29147793
[TBL] [Abstract][Full Text] [Related]
9. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
Lin KH; Ali A; Rusere L; Soumana DI; Kurt Yilmaz N; Schiffer CA
J Virol; 2017 May; 91(10):. PubMed ID: 28298600
[TBL] [Abstract][Full Text] [Related]
10. Discovery of antiviral molecules for dengue: In silico search and biological evaluation.
Cabarcas-Montalvo M; Maldonado-Rojas W; Montes-Grajales D; Bertel-Sevilla A; Wagner-Döbler I; Sztajer H; Reck M; Flechas-Alarcon M; Ocazionez R; Olivero-Verbel J
Eur J Med Chem; 2016 Mar; 110():87-97. PubMed ID: 26807547
[TBL] [Abstract][Full Text] [Related]
11. 3D-QSAR and molecular docking studies of peptide-hybrids as dengue virus NS2B/NS3 protease inhibitors.
Jitonnom J; Meelua W; Tue-Nguen P; Saparpakorn P; Hannongbua S; Chotpatiwetchkul W
Chem Biol Interact; 2024 Jun; 396():111040. PubMed ID: 38735453
[TBL] [Abstract][Full Text] [Related]
12. Discovery and design of cyclic peptides as dengue virus inhibitors through structure-based molecular docking.
Idrees S; Ashfaq UA
Asian Pac J Trop Med; 2014 Jul; 7(7):513-6. PubMed ID: 25063278
[TBL] [Abstract][Full Text] [Related]
13. Design, structure-based focusing and in silico screening of combinatorial library of peptidomimetic inhibitors of Dengue virus NS2B-NS3 protease.
Frecer V; Miertus S
J Comput Aided Mol Des; 2010 Mar; 24(3):195-212. PubMed ID: 20306283
[TBL] [Abstract][Full Text] [Related]
14. Discovery and SAR studies of methionine-proline anilides as dengue virus NS2B-NS3 protease inhibitors.
Zhou GC; Weng Z; Shao X; Liu F; Nie X; Liu J; Wang D; Wang C; Guo K
Bioorg Med Chem Lett; 2013 Dec; 23(24):6549-54. PubMed ID: 24268549
[TBL] [Abstract][Full Text] [Related]
15. A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells.
Beesetti H; Tyagi P; Medapi B; Krishna VS; Sriram D; Khanna N; Swaminathan S
Antivir Ther; 2018; 23(5):385-394. PubMed ID: 29583121
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Ganoderma lucidum triterpenoids as potential inhibitors against Dengue virus NS2B-NS3 protease.
Bharadwaj S; Lee KE; Dwivedi VD; Yadava U; Panwar A; Lucas SJ; Pandey A; Kang SG
Sci Rep; 2019 Dec; 9(1):19059. PubMed ID: 31836806
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of new potent inhibitors of dengue virus NS5 proteinase from Andrographis paniculata supercritical extracts on in animal cell culture and in silico approaches.
Kaushik S; Dar L; Kaushik S; Yadav JP
J Ethnopharmacol; 2021 Mar; 267():113541. PubMed ID: 33152438
[TBL] [Abstract][Full Text] [Related]
18. 3D-QSAR pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation toward identifying lead compounds for NS2B-NS3 protease inhibitors.
Luo PH; Zhang XR; Huang L; Yuan L; Zhou XZ; Gao X; Li LS
J Recept Signal Transduct Res; 2017 Oct; 37(5):481-492. PubMed ID: 28758854
[TBL] [Abstract][Full Text] [Related]
19. Structure-guided Discovery of a Novel Non-peptide Inhibitor of Dengue Virus NS2B-NS3 Protease.
Li L; Basavannacharya C; Chan KW; Shang L; Vasudevan SG; Yin Z
Chem Biol Drug Des; 2015 Sep; 86(3):255-64. PubMed ID: 25533891
[TBL] [Abstract][Full Text] [Related]
20. A Computational Approach Applied to the Study of Potential Allosteric Inhibitors Protease NS2B/NS3 from Dengue Virus.
Costa RAD; Rocha JAPD; Pinheiro AS; Costa ADSSD; Rocha ECMD; Silva RC; Gonçalves ADS; Santos CBR; Brasil DDSB
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]